Net Profit Margin
since 2005
Calculation
Abbott Laboratories, net profit margin, long-term trends, calculation
| Net profit margin | = | 100 | × | Net earnings1 | ÷ | Net sales1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 14.27% | = | 100 | × | 5,723) | ÷ | 40,109) |
| Dec 31, 2022 | 15.88% | = | 100 | × | 6,933) | ÷ | 43,653) |
| Dec 31, 2021 | 16.42% | = | 100 | × | 7,071) | ÷ | 43,075) |
| Dec 31, 2020 | 12.99% | = | 100 | × | 4,495) | ÷ | 34,608) |
| Dec 31, 2019 | 11.56% | = | 100 | × | 3,687) | ÷ | 31,904) |
| Dec 31, 2018 | 7.74% | = | 100 | × | 2,368) | ÷ | 30,578) |
| Dec 31, 2017 | 1.74% | = | 100 | × | 477) | ÷ | 27,390) |
| Dec 31, 2016 | 6.71% | = | 100 | × | 1,400) | ÷ | 20,853) |
| Dec 31, 2015 | 21.68% | = | 100 | × | 4,423) | ÷ | 20,405) |
| Dec 31, 2014 | 11.28% | = | 100 | × | 2,284) | ÷ | 20,247) |
| Dec 31, 2013 | 11.79% | = | 100 | × | 2,576) | ÷ | 21,848) |
| Dec 31, 2012 | 14.95% | = | 100 | × | 5,963) | ÷ | 39,874) |
| Dec 31, 2011 | 12.17% | = | 100 | × | 4,728) | ÷ | 38,851) |
| Dec 31, 2010 | 13.15% | = | 100 | × | 4,626) | ÷ | 35,167) |
| Dec 31, 2009 | 18.68% | = | 100 | × | 5,746) | ÷ | 30,765) |
| Dec 31, 2008 | 16.53% | = | 100 | × | 4,881) | ÷ | 29,528) |
| Dec 31, 2007 | 13.92% | = | 100 | × | 3,606) | ÷ | 25,914) |
| Dec 31, 2006 | 7.64% | = | 100 | × | 1,717) | ÷ | 22,476) |
| Dec 31, 2005 | 15.10% | = | 100 | × | 3,372) | ÷ | 22,338) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
Comparison to Competitors
Abbott Laboratories, net profit margin, long-term trends, comparison to competitors
| Abbott Laboratories | Cigna Group | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 14.27% | 2.66% | 2.34% | 3.52% | 25.24% | 12.03% | 6.09% |
| Dec 31, 2022 | 15.88% | 3.72% | 1.29% | 3.87% | 21.25% | 15.90% | 6.25% |
| Dec 31, 2021 | 16.42% | 3.11% | 2.72% | 4.46% | 29.85% | 11.97% | 6.06% |
| Dec 31, 2020 | 12.99% | 5.31% | 2.68% | 3.78% | 24.33% | 16.56% | 6.03% |
| Dec 31, 2019 | 11.56% | 3.35% | 2.59% | 4.66% | 30.80% | 15.16% | 5.76% |
| Dec 31, 2018 | 7.74% | 5.59% | -0.31% | 4.11% | 30.29% | 10.36% | 5.33% |
| Dec 31, 2017 | 1.74% | 5.51% | 3.58% | 4.31% | 21.09% | 13.56% | 5.28% |
| Dec 31, 2016 | 6.71% | 4.87% | 3.00% | 2.93% | 27.21% | 12.27% | 3.81% |
| Dec 31, 2015 | 21.68% | 5.71% | 3.42% | 3.27% | 24.69% | 13.20% | 3.72% |
| Dec 31, 2014 | 11.28% | 6.26% | 3.33% | 3.52% | 19.65% | 18.02% | 4.33% |
| Dec 31, 2013 | 11.79% | 4.76% | 3.62% | 3.55% | 29.62% | 20.90% | 4.62% |
| Dec 31, 2012 | 14.95% | 5.81% | 3.15% | 4.37% | 30.14% | 22.35% | 5.03% |
| Dec 31, 2011 | 12.17% | 6.38% | 3.23% | 4.42% | 28.17% | 19.43% | 5.08% |
| Dec 31, 2010 | 13.15% | 6.70% | 3.55% | 4.99% | 27.02% | 19.59% | 4.95% |
| Dec 31, 2009 | 18.68% | 7.46% | 3.74% | 7.80% | 22.11% | 14.86% | 4.42% |
| Dec 31, 2008 | 16.53% | 1.60% | 3.67% | 4.04% | 23.35% | 16.51% | 3.70% |
| Dec 31, 2007 | 13.92% | 6.76% | 3.45% | 5.56% | 24.06% | 22.78% | 6.26% |
| Dec 31, 2006 | 7.64% | 7.63% | 3.12% | 5.52% | 19.33% | 22.55% | 5.89% |
| Dec 31, 2005 | 15.10% | 10.60% | 3.31% | 5.53% | 41.41% | 17.94% | 7.36% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Abbott Laboratories, net profit margin, long-term trends, comparison to sector (health care equipment & services)
| Abbott Laboratories | Health Care Equipment & Services | |
|---|---|---|
| Dec 31, 2023 | 14.27% | 4.56% |
| Dec 31, 2022 | 15.88% | 4.74% |
| Dec 31, 2021 | 16.42% | 5.08% |
| Dec 31, 2020 | 12.99% | 5.27% |
| Dec 31, 2019 | 11.56% | 4.90% |
| Dec 31, 2018 | 7.74% | 3.92% |
| Dec 31, 2017 | 1.74% | 4.95% |
| Dec 31, 2016 | 6.71% | 4.17% |
| Dec 31, 2015 | 21.68% | 5.00% |
| Dec 31, 2014 | 11.28% | 4.99% |
| Dec 31, 2013 | 11.79% | 5.35% |
| Dec 31, 2012 | 14.95% | 6.29% |
| Dec 31, 2011 | 12.17% | 6.05% |
| Dec 31, 2010 | 13.15% | 6.37% |
| Dec 31, 2009 | 18.68% | 7.01% |
| Dec 31, 2008 | 16.53% | 5.59% |
| Dec 31, 2007 | 13.92% | 6.88% |
| Dec 31, 2006 | 7.64% | 6.42% |
| Dec 31, 2005 | 15.10% | 7.96% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Abbott Laboratories, net profit margin, long-term trends, comparison to industry (health care)
| Abbott Laboratories | Health Care | |
|---|---|---|
| Dec 31, 2023 | 14.27% | 8.47% |
| Dec 31, 2022 | 15.88% | 10.74% |
| Dec 31, 2021 | 16.42% | 11.33% |
| Dec 31, 2020 | 12.99% | 8.06% |
| Dec 31, 2019 | 11.56% | 10.52% |
| Dec 31, 2018 | 7.74% | 9.71% |
| Dec 31, 2017 | 1.74% | 7.94% |
| Dec 31, 2016 | 6.71% | 10.43% |
| Dec 31, 2015 | 21.68% | 11.49% |
| Dec 31, 2014 | 11.28% | 11.88% |
| Dec 31, 2013 | 11.79% | 12.44% |
| Dec 31, 2012 | 14.95% | 11.61% |
| Dec 31, 2011 | 12.17% | 10.36% |
| Dec 31, 2010 | 13.15% | 10.35% |
| Dec 31, 2009 | 18.68% | 14.83% |
| Dec 31, 2008 | 16.53% | 11.00% |
| Dec 31, 2007 | 13.92% | 10.87% |
| Dec 31, 2006 | 7.64% | 13.71% |
| Dec 31, 2005 | 15.10% | 13.26% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).